ANIP News and Press, ANI Pharmaceuticals Inc. From 08/06/20

ANI Pharmaceuticals (NASDAQ: ANIP ) : Q2 Non-GAAP EPS of $0.69 misses by $0.06 ; GAAP EPS of -$1.03 misses by $1.19 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

- Second quarter 2020 net revenues of $48.5 million - - Nikhil Lalwani named President and CEO, effective September 8, 2020 – - Pharmaceutical industry executives, Jeanne Thoma and Tony Pera, join Board of Directors - ANI Pharmaceuticals, Inc. (“ANI” or ...

Additions reflect ANI’s commitment to broaden pharmaceutical industry experience on Board ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Officer of SPI P...

Effective September 8, ANI Pharmaceuticals (NASDAQ: ANIP ) appoints  Nikhil Lalwani as President and CEO succeeding Patrick D. Walsh More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

-Accomplished leader with proven record of achievement to drive next phase of Company’s growth- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chi...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets. Patrick Walsh, Interim Presi...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

BAUDETTE, Minn. , July 6, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the acquisition of Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company for $3.0 million .  The current annual U.S. market for this product i...

BAUDETTE, Minn. , June 30, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million , according to IQ...

Ignorance is relatively easy to overcome; stupidity is much harder. "― Marty Rubin Today, we take a look at a stock that has fallen on some hard times as it jettisoned its long-term CEO and faced other short-term challenges. However, with management changes and other potential cata...